[EN] TRIAZOLO `1 , 5-A!PYRIMIDINES AND THEIR USE IN MEDICINE<br/>[FR] TRIAZOLO`1,5-A!PYRIMIDINES ET LEUR UTILISATION EN MEDECINE
申请人:VERNALIS CAMBRIDGE LTD
公开号:WO2004108136A1
公开(公告)日:2004-12-16
Compounds of formula (IA) or (AB) are kinase inhibitors, especially of CDK2, and/or PDK1 and/or CHK 1: wherein Ring A is an optionally substituted aryl, heteroaryl, carbocyclic or heterocyclic radical, Alk represents an optionally substituted clivaient C1-C6 alkylene radical; n is 0 or 1; Q represents a radical of formula -(Alk1)p-(X),(Alk 2)s-Z wherein in any compatible combination Z is hydrogen or an optionally substituted carbocyclic or heterocyclic ring, p, r and s are 0 or 1, and Alk1, Alk 2, X, are as described in the specification, and R1 represents a radical 3 4 3 (CYC)k-(Alk3)a-(Y)b-(Alk4)d-B wherein k, a, b and d are 0 or 1, and Cyc, Alk3, Alk 4 and B are as described in the specification.
公式(IA)或(AB)的化合物是激酶抑制剂,特别是CDK2,和/或PDK1和/或CHK 1:其中环A是一个可选择取代的芳基,杂环芳基,碳环或杂环基,Alk代表一个可选择取代的C1-C6烷基基团;n为0或1;Q代表一个公式-(Alk1)p-(X),(Alk 2)s-Z的基团,在任何兼容的组合中,Z是氢或一个可选择取代的碳环或杂环环,p,r和s为0或1,Alk1,Alk 2,X,如说明书中所述,R1代表一个基团3 4 3(CYC)k-(Alk3)a-(Y)b-(Alk4)d-B,其中k,a,b和d为0或1,Cyc,Alk3,Alk 4和B如说明书中所述。